David Shaw’s Replimune Group REPL Stock Holding History

David Shaw’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.21M	Buy	+200,000	New	+$1.22M	﹤0.01%	3112

Other funds holding REPL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

RCI

Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

David Shaw's REPL Position: Q2 2026 in Review

David Shaw reduced its Replimune Group (REPL) stake by 23% in Q2 2026, selling an estimated $3.34M and leaving 1,789,964 shares worth $19.8M. The position accounts for 0.01% of the portfolio, ranked #1286.

David Shaw first reported a position in REPL in Q3 2020 and has held it in 19 quarters since. The position peaked at $25M in Q4 2025. 198 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

David Shaw held 1,789,964 shares of Replimune Group worth $19.8M as of Q2 2026.
David Shaw sold 546,564 Replimune Group shares in Q2 2026, an estimated $3.34M.
Replimune Group made up 0.01% of David Shaw's portfolio in Q2 2026, its #1286 holding.
David Shaw first reported a position in Replimune Group in Q3 2020 and has held it in 19 quarters since.
David Shaw's Replimune Group position peaked at $25M in Q4 2025.
198 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.